Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hungarian Study of Rituximab Maintenance After Rituximab-Containing Induction
2005-000359-13Phase 3Completed
- Sponsor
- Roche
- Start
- Mar 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of rituximab in follicular lymphoma (FL) (2 arms), sponsored by Roche. Primary endpoints: Event-free survival and Progression-free survival. Started Mar 2005; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on 2005-000359-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000359-13.